0
Albireo Pharma, Inc. Banner Image

Albireo Pharma, Inc. has reached its limit for free report views

Work for Albireo Pharma, Inc.? Upgrade Your Profile and unlock all your annual reports.

Albireo Pharma, Inc.

  • Ticker ALBO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Albireo Pharma, Inc. Logo Image
  • 51-200 Employees
  • Based in Boston, Massachusetts
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other liver and gastrointestinal diseases and disorders. Albireo’s lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases and is in Phase 3 development in progressive familialMore intrahepatic cholestasis (PFIC) and biliary atresia, with a third Phase 3 trial being planned in Alagille syndrome. Albireo was spun out from AstraZeneca in 2008. Albireo Pharma is located in Boston, Mass., and its key operating subsidiary is located in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Albireo Pharma, Inc.

Most Recent Annual Report

Albireo Pharma, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Albireo Pharma, Inc. has reached its limit for free report views.